Periodontal Phenotype and Scaling and Root Planing

NCT ID: NCT05449938

Last Updated: 2022-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-01

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Periodontal phenotype has been recognized as one of the key factors that may potentially impact the outcome of a variety of periodontal surgical and non-surgical procedures. Taking into consideration the inconsistent findings of the studies done in this regard,outcomes of scaling and root planing with respect to periodontal phenotype.

With this aim, the present study would be conducted to assess the influence of periodontal phenotype on outcome of scaling and root planing in periodontitis patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

AIM: To evaluate the influence of periodontal phenotype on the outcomes of scaling and root planing in periodontitis patients.

OBJECTIVES:

To assess the improvement in pocket probing depth (PPD), clinical attachment level (CAL), bleeding in pocket probing (BOPP), bleeding on marginal probing (BOMP), gingival marginal position (GMP), gingival recession (GR), plaque index (PI), and gingival index (GI) after scaling and root planing (SRP) in periodontitis patients with thin or thick periodontal phenotype.

SETTING: Department of periodontics and oral implantology, PGIDS, Rohtak, Haryana.

STUDY DESIGN: Comparative Interventional study.

TIME FRAME: 12 months (september 2021- August 2022)

POPULATION:

Systemically healthy patients with periodontitis (periodontitis stage II and stage III) and thin/thick periodontal phenotype in maxillary and mandibular incisors will be included.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thick periodontal phenotype

Stage II and stage III periodontitis Patient with thick periodontal phenotype will be enrolled using probe transparency method .

Group Type EXPERIMENTAL

Scaling and root planing

Intervention Type PROCEDURE

Scaling and root planing involves removal of plaque and calculus on tooth surface.

Thin periodontal phenotype

Stage II and stage III periodontitis Patient with thin periodontal phenotype will be enrolled using probe transparency method.

Group Type ACTIVE_COMPARATOR

Scaling and root planing

Intervention Type PROCEDURE

Scaling and root planing involves removal of plaque and calculus on tooth surface.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Scaling and root planing

Scaling and root planing involves removal of plaque and calculus on tooth surface.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Systemically healthy patients with periodontitis (periodontitis stage 2 and stage 3) and thin/thick periodontal phenotype in maxillary and mandibular incisors will be included.

Exclusion Criteria

* Systemic condition known to affect the course of periodontal disease like diabetes mellitus or immunogenic disorders.
* Patient on anti-inflammatory drugs or antibiotics or history of treatment with medication known to influence periodontal status or healing within last 2 years.
* Current or former smoker or use of tobacco in any form
* History of periodontal treatment in last 2 years
* Crowding in anterior teeth.
* Pregnant or lactating females.
* Individuals with restorations on anterior teeth.
Minimum Eligible Age

35 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Postgraduate Institute of Dental Sciences Rohtak

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Krishan Kant, BDS

Role: PRINCIPAL_INVESTIGATOR

POST GRADUATE INSTITUTE OF DENTAL SCIENCES ROHTAK

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Post Graduate Institute Of Dental Science

Rohtak, Haryana, India

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

India

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rajinder Kr Sharma, MDS

Role: CONTACT

9416358222

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sanjay Tewari, MDS

Role: primary

01262283876

Ambika Gupta, MDS

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Krishan kant perio

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.